Who owns DRUG?
Institutional ownership of Bright Minds Biosciences Inc. from Form 13F, Q2 2026
100 institutional managers reported holding Bright Minds Biosciences Inc. (DRUG) in Form 13F filings for Q2 2026, with 9,311,244 shares worth $654M. The largest reported holder was Jupiter Topco LLC. Managers that filed both quarters added a net 58,121 shares (+0.7%). 19 opened new positions and 11 sold out.
- Funds holding
- 100
- Value held
- $654M
- New / sold out
- 19 / 11
- Net shares, same filers
- +0.7%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of DRUG
Share of 13F holdings is each fund's shares as a share of the 9,311,244 DRUG shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Point72 Asset Management, L.P. New+$23.0M
- Parkman Healthcare Partners LLC Added+$11.6M
- Citadel Advisors LLC New+$4.7M
- BlackRock, Inc. Added+$4.5M
- Trexquant Investment LP Added+$4.4M
- Goldman Sachs Group Inc Added+$4.2M
- Schonfeld Strategic Advisors LLC Added+$3.7M
- Orbimed Advisors LLC Added+$3.7M
- Vestal Point Capital, LP Added+$3.7M
- Balyasny Asset Management L.P. Added+$3.4M
Biggest sellers in Q2 2026
- Perceptive Advisors LLC Sold out-$27.5M
- Adage Capital Partners GP, L.l.c. Trimmed-$11.3M
- Cormorant Asset Management, LP Trimmed-$11.2M
- Morgan Stanley Trimmed-$8.0M
- Great Point Partners LLC Trimmed-$7.7M
- Ikarian Capital, LLC Trimmed-$5.5M
- Braidwell LP Trimmed-$3.9M
- Boothbay Fund Management, LLC Trimmed-$1.6M
- Acuta Capital Partners, LLC Trimmed-$1.4M
- D. E. Shaw & Co., Inc. Sold out-$1.1M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $88.4M and sold $85.5M; 47 added and 17 trimmed.
Schedule 13D and 13G filings on DRUG
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-11-13Adage Capital Management, L.P. SCHEDULE 13G filed by Bright Minds Biosciences Inc.Schedule 13G
- 2025-04-08Sio Capital Management, LLC SCHEDULE 13G filed by Bright Minds Biosciences Inc.Schedule 13G
- 2025-02-10Sio Capital Management, LLC SCHEDULE 13G filed by Bright Minds Biosciences Inc.Schedule 13G
- 2025-02-07JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by Bright Minds Biosciences Inc.Schedule 13G
Questions about DRUG ownership
- Who owns DRUG stock?
- 100 institutional investment managers reported DRUG positions in their Form 13F filings for Q2 2026, holding 9,311,244 shares worth $654M in total. Jupiter Topco LLC reported the largest position.
- Are funds buying or selling DRUG?
- In Q2 2026, 19 managers opened new DRUG positions, 47 added, 17 trimmed and 11 sold out. Managers that filed in both quarters added a net 58,121 shares.
- How current is this DRUG institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to DRUG by CUSIP. Options are left out. DRUG news and filings · DRUG insider trades · Top funds